MetaADEDB 2.0 @ LMMD
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine
(UZWDCWONPYILKI-UHFFFAOYSA-N)
Structure
SMILES
CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F
Type(s)
Approved; Investigational
ATC code(s)
L01XE50
Molecular Formula:
C27H32F2N8
Molecular Weight:
506.593
Log P:
4.8857
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
75
CAS Number(s):
1231929-97-7
Synonym(s)
1.
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine
2.
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine
3.
LY2385219
4.
LY2835210
5.
LY2835219
6.
abemaciclib
External Link(s)
MeSHC000590451
PubChem Compound46220502
BindingDB50110183
CHEMBLCHEMBL3301610
DrugBankDB12001
DrugCentral5259
IUPHAR/BPS Guide to PHARMACOLOGY7382
KEGGdr:D10688
Therapeutic Target DatabaseD05SBO
ZINC72318121
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 115US FAERS
2FatigueFAERS: 102US FAERS
3VomitingFAERS: 75US FAERS
4DehydrationFAERS: 43US FAERS
5White blood cell count decreasedFAERS: 42US FAERS
6Drug ineffectiveFAERS: 35US FAERS
7Malignant neoplasm progressionFAERS: 34US FAERS
8Therapy cessationFAERS: 27US FAERS
9ConstipationFAERS: 25US FAERS
10AstheniaFAERS: 24US FAERS
11Abdominal PainFAERS: 22US FAERS
12DizzinessFAERS: 21US FAERS
13Weight decreasedFAERS: 21US FAERS
14Blood creatinine increasedFAERS: 19US FAERS
15AlopeciaFAERS: 18US FAERS
16Disease ProgressionFAERS: 18US FAERS
17MalaiseFAERS: 16US FAERS
18HeadacheFAERS: 14US FAERS
19Abdominal discomfortFAERS: 12US FAERS
20DysgeusiaFAERS: 11US FAERS
21Peripheral swellingFAERS: 11US FAERS
22PneumoniaFAERS: 10US FAERS
23Therapy changeFAERS: 10US FAERS
24Urinary tract infectionFAERS: 10US FAERS
25Acute kidney injuryFAERS: 8US FAERS
26ArthralgiaFAERS: 8US FAERS
27NeutropeniaFAERS: 8US FAERS
28Drug dose omissionFAERS: 7US FAERS
29Neutrophil count decreasedFAERS: 7US FAERS
30Product dose omissionFAERS: 7US FAERS
31PruritusFAERS: 7US FAERS
32ThrombosisFAERS: 7US FAERS
33Back PainFAERS: 6US FAERS
34CytopeniaFAERS: 6US FAERS
35Feeling abnormalFAERS: 6US FAERS
36RetchingFAERS: 6US FAERS
37Blood count abnormalFAERS: 5US FAERS
38Full blood count decreasedFAERS: 5US FAERS
39HypotensionFAERS: 5US FAERS
40PainFAERS: 5US FAERS
41Pulmonary EmbolismFAERS: 5US FAERS
42TachycardiaFAERS: 5US FAERS
43Atrial FibrillationFAERS: 4US FAERS
44CystitisFAERS: 4US FAERS
45FlatulenceFAERS: 4US FAERS
46Gait inabilityFAERS: 4US FAERS
47HypophagiaFAERS: 4US FAERS
48Joint swellingFAERS: 4US FAERS
49Memory impairmentFAERS: 4US FAERS
50NasopharyngitisFAERS: 4US FAERS
51SyncopeFAERS: 4US FAERS
52ThrombocytopeniaFAERS: 4US FAERS
53TremorFAERS: 4US FAERS
54Unevaluable eventFAERS: 4US FAERS
55treatment failureFAERS: 4US FAERS
56BlindnessFAERS: 3US FAERS
57Blood glucose decreasedFAERS: 3US FAERS
58Blood magnesium decreasedFAERS: 3US FAERS
59Cerebrovascular accidentFAERS: 3US FAERS
60Chest PainFAERS: 3US FAERS
61ColitisFAERS: 3US FAERS
62Feeling ColdFAERS: 3US FAERS
63MyalgiaFAERS: 3US FAERS
64PneumothoraxFAERS: 3US FAERS
65SinusitisFAERS: 3US FAERS
66SomnolenceFAERS: 3US FAERS
67StomatitisFAERS: 3US FAERS
68SwellingFAERS: 3US FAERS
69Alanine Aminotransferase IncreasedFAERS: 2US FAERS
70AscitesFAERS: 2US FAERS
71Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
72AsthmaFAERS: 2US FAERS
73Blood alkaline phosphatase increasedFAERS: 2US FAERS
74Burning sensationFAERS: 2US FAERS
75Cerebral disorderFAERS: 2US FAERS
76Deep Vein ThrombosisFAERS: 2US FAERS
77DeliriumFAERS: 2US FAERS
78DysphoniaFAERS: 2US FAERS
79Electrolyte imbalanceFAERS: 2US FAERS
80ErythemaFAERS: 2US FAERS
81Feeling jitteryFAERS: 2US FAERS
82FractureFAERS: 2US FAERS
83Full blood count abnormalFAERS: 2US FAERS
84Hospice CareFAERS: 2US FAERS
85HypersensitivityFAERS: 2US FAERS
86InfluenzaFAERS: 2US FAERS
87Intentional product misuseFAERS: 2US FAERS
88Ligament ruptureFAERS: 2US FAERS
89Limb discomfortFAERS: 2US FAERS
90Lip swellingFAERS: 2US FAERS
91Mouth swellingFAERS: 2US FAERS
92Musculoskeletal stiffnessFAERS: 2US FAERS
93Myocardial InfarctionFAERS: 2US FAERS
94OnychoclasisFAERS: 2US FAERS
95OnycholysisFAERS: 2US FAERS
96Oral painFAERS: 2US FAERS
97Oropharyngeal painFAERS: 2US FAERS
98OverdoseFAERS: 2US FAERS
99Pain of skinFAERS: 2US FAERS
100PallorFAERS: 2US FAERS
101Platelet count abnormalFAERS: 2US FAERS
102PneumonitisFAERS: 2US FAERS
103Product dispensing errorFAERS: 2US FAERS
104Product outer packaging issueFAERS: 2US FAERS
105Product use issueFAERS: 2US FAERS
106RestlessnessFAERS: 2US FAERS
107ScabFAERS: 2US FAERS
108Skin irritationFAERS: 2US FAERS
109SomnambulismFAERS: 2US FAERS
110Therapy non-responderFAERS: 2US FAERS
111Throat irritationFAERS: 2US FAERS
112Visual ImpairmentFAERS: 2US FAERS
113White blood cell count abnormalFAERS: 2US FAERS
114Wrong technique in product usage processFAERS: 2US FAERS
115Abdominal InfectionFAERS: 1US FAERS
116AbscessFAERS: 1US FAERS
117Adverse eventFAERS: 1US FAERS
118AgeusiaFAERS: 1US FAERS
119Altered state of consciousnessFAERS: 1US FAERS
120AmnesiaFAERS: 1US FAERS
121AnxietyFAERS: 1US FAERS
122Aortic occlusionFAERS: 1US FAERS
123AphoniaFAERS: 1US FAERS
124ArthritisFAERS: 1US FAERS
125ArthropathyFAERS: 1US FAERS
126Blister ruptureFAERS: 1US FAERS
127Blood glucose increasedFAERS: 1US FAERS
128Blood potassium decreasedFAERS: 1US FAERS
129Blood sodium increasedFAERS: 1US FAERS
130Bone painFAERS: 1US FAERS
131BronchitisFAERS: 1US FAERS
132ChillsFAERS: 1US FAERS
133CholelithiasisFAERS: 1US FAERS
134Clostridium difficile infectionFAERS: 1US FAERS
135Coronary artery embolismFAERS: 1US FAERS
136Creatinine renal clearance decreasedFAERS: 1US FAERS
137DiplopiaFAERS: 1US FAERS
138Discontinued product administeredFAERS: 1US FAERS
139Drug level increasedFAERS: 1US FAERS
140Dry skinFAERS: 1US FAERS
141DysarthriaFAERS: 1US FAERS
142DyspepsiaFAERS: 1US FAERS
143DystoniaFAERS: 1US FAERS
144DysuriaFAERS: 1US FAERS
145Emergency CareFAERS: 1US FAERS
146EpistaxisFAERS: 1US FAERS
147EructationFAERS: 1US FAERS
148Essential TremorFAERS: 1US FAERS
149Eyelids pruritusFAERS: 1US FAERS
150Female Orgasmic DisorderFAERS: 1US FAERS
151FibrosisFAERS: 1US FAERS
152FlushingFAERS: 1US FAERS
153Gastroenteritis norovirusFAERS: 1US FAERS
154GastroenteritisFAERS: 1US FAERS
155Gastrointestinal toxicityFAERS: 1US FAERS
156Genital rashFAERS: 1US FAERS
157Hip surgeryFAERS: 1US FAERS
158Impaired quality of lifeFAERS: 1US FAERS
159Inappropriate schedule of drug administrationFAERS: 1US FAERS
160Inappropriate schedule of product administrationFAERS: 1US FAERS
161Incorrect dose administeredFAERS: 1US FAERS
162InfectionFAERS: 1US FAERS
163InflammationFAERS: 1US FAERS
164Intestinal ObstructionFAERS: 1US FAERS
165LethargyFAERS: 1US FAERS
166LeukoencephalopathyFAERS: 1US FAERS
167LeukopeniaFAERS: 1US FAERS
168Loss of personal independence in daily activitiesFAERS: 1US FAERS
169Lymphangiosis carcinomatosaFAERS: 1US FAERS
170LymphopeniaFAERS: 1US FAERS
171MastitisFAERS: 1US FAERS
172Mental status changesFAERS: 1US FAERS
173Metastatic NeoplasmFAERS: 1US FAERS
174Multiple SclerosisFAERS: 1US FAERS
175Muscle tightnessFAERS: 1US FAERS
176Musculoskeletal PainFAERS: 1US FAERS
177Neck PainFAERS: 1US FAERS
178NecrosisFAERS: 1US FAERS
179NeuralgiaFAERS: 1US FAERS
180Oral mucosal eruptionFAERS: 1US FAERS
181Osteonecrosis of JawFAERS: 1US FAERS
182PalpitationsFAERS: 1US FAERS
183PancreatitisFAERS: 1US FAERS
184Paranasal sinus discomfortFAERS: 1US FAERS
185Pericardial effusionFAERS: 1US FAERS
186Peripheral artery thrombosisFAERS: 1US FAERS
187Peripheral embolismFAERS: 1US FAERS
188PleurisyFAERS: 1US FAERS
189Post procedural infectionFAERS: 1US FAERS
190PresyncopeFAERS: 1US FAERS
191Product dispensing issueFAERS: 1US FAERS
192Product use complaintFAERS: 1US FAERS
193Pulmonary thrombosisFAERS: 1US FAERS
194Quality of life decreasedFAERS: 1US FAERS
195Radiation PneumonitisFAERS: 1US FAERS
196Respiratory FailureFAERS: 1US FAERS
197Respiratory arrestFAERS: 1US FAERS
198Respiratory distressFAERS: 1US FAERS
199RosaceaFAERS: 1US FAERS
200SepsisFAERS: 1US FAERS
201Skin UlcerFAERS: 1US FAERS
202ThirstFAERS: 1US FAERS
203Toxicity to various agentsFAERS: 1US FAERS
204Transaminases increasedFAERS: 1US FAERS
205Upper-airway cough syndromeFAERS: 1US FAERS
206VertigoFAERS: 1US FAERS
207Vocal Cord ParalysisFAERS: 1US FAERS
208Vulvovaginal pruritusFAERS: 1US FAERS
209furuncleFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.